US Patent Issued to Daiichi Sankyo on July 28 for "Griseofulvin compound and pharmaceutical use thereof" (Japanese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,258, issued on July 28, was assigned to Daiichi Sankyo Co. Ltd. (Tokyo).

"Griseofulvin compound and pharmaceutical use thereof" was invented by Keiji Saito (Atsugi, Japan), Katsuyoshi Nakajima (Shinagawa-ku, Japan), Yasuyuki Ogawa (Yokosuka, Japan), Mitsuhiro Makino (Shinagawa-ku, Japan), Kaori Ito (Koto-ku, Japan), Seiko Nagata (Shinagawa-ku, Japan) and Makoto Hirasawa (Shinagawa-ku, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention addresses the problem of providing a compound for prophylaxis and/or treatment of central inflammatory diseases, or a pharmacologically acceptable salt thereof. The present invention addresses a...